🚨 Now recruiting at the DDU: ASpiRE, a Phase I/II trial for metastatic castration-resistant prostate cancer (mCRPC), testing SX-682 + Apalutamide. Help shape the future of prostate cancer care.

📍Royal Marsden, Sutton

🔗ClinicalTrials.gov (NCT07002320)

#ProstateCancer #ASpiRETrial #DDU #ICR